Expert Panel's Decision to Recommend Against Routine HCV Screening Draws Community Ire By Tracy Swan "Inconsistent With Other Bodies" In March of 2004, the U.S. Prevention Services Task Force's "Screening for Hepatitis C Virus Infection in Adults: Recommendation Statement" was…
XI CROI, Stage for Results of Three Large HCV Treatment Trials By Tracy Swan Still No Head-to-Head Eagerly awaited results from three pivotal safety and efficacy studies of HCV treatment in HIV/HCV coinfected individuals were presented at the 11th Conference…
Proliferation of Polymerase Inhibitors and Other Tales From the HCV Crypt By Tracy Swan Building a Better Ribavirin Liver disease has become increasingly prominent in the HAART era. Hepatitis C progresses more rapidly in HIV-positive people, and is more difficult…
by Rob Camp January: starts as new TAG's Antiviral Project Director. Rob and Mark to Houston for ATAC structure meeting to develop stronger national coalition, then to D.C. for Federal AIDS Policy Partnership meeting. Talk of coming assault on Medicaid…
Expediency, Cost-Cutting Trump Science in Peg-Intron Clinical Development Plan By Tracy Swan The Head-to-Head That Wasn't In October of 2003, Schering-Plough held a meeting with HCV and HIV/HCV advocates where they announced a "new" Schering -- one that prioritizes earning…
January: HIV vaccine papers in Nature by Merck's Emilio Emini, Harvard's Dan Barouch. February: First ATAC (AIDS Treatment Activist Conference) teach-in, Seattle (seventy people attend), followed by ATAC/BMS meeting and Retrovirus conference. NIH cancels large phase III canarypox HIV vaccine…
January: TAG's Gregg Gonsalves becomes GMHC Director of Treatment Policy. Completion of STI Workshop 2000 report. FDA hearing on salvage therapy trial design. Merck meeting on promising DNA/adenovirus HIV vaccine. TAG mobilizes 600 signatures on global letter to Glaxo decrying…
January: NIH workshops on long term effectiveness research, studies designed to look at "when to start" and switch HAART, and for long-term side effects. TAG hires Yvette Delph as new Antiviral Project Director. Completion of TAG's AIDS Vaccine Research at…
Critical Issues From TAG's Forthcoming HCV/HIV Co-Infection Report and Analysis By Tracy Swan Research Still Lags Tracy Swan's teaser sneak preview of her upcoming Hepatitis C/HIV Co-infection Report (Version 2.0), slated for release this spring, is now available as both…
January: amfAR's Paul Corser dies after a nine-year struggle with AIDS. FDA approves Glaxo's atovaquone (Mepron) for the prevention of PCP pneumonia. ACT UP/Needle Exchange activist Rod Sorge dies. Retrovirus conference, Chicago. Beatrice Hahn presents on the HIV-1's chimp origins;…